Literature DB >> 8789980

Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals.

T C Egberts1, M Smulders, F H de Koning, R H Meyboom, H G Leufkens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8789980      PMCID： PMC2351951          DOI： 10.1136/bmj.313.7056.530

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Comparison of 500 spontaneous and 500 published reports of adverse drug reactions.

Authors:  F Haramburu; B Bégaud; J C Péré
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems.

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05

3.  Discovery of new adverse drug reactions. A review of the Food and Drug Administration's spontaneous reporting system.

Authors:  A C Rossi; D E Knapp
Journal:  JAMA       Date:  1984 Aug 24-31       Impact factor: 56.272

4.  Patients as a direct source of information on adverse drug reactions.

Authors:  A S Mitchell; D A Henry; R Sanson-Fisher; D L O'Connell
Journal:  BMJ       Date:  1988-10-08
  4 in total
  31 in total

Review 1.  Pharmacovigilance in perspective.

Authors:  R H Meyboom; A C Egberts; F W Gribnau; Y A Hekster
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

Review 2.  What can consumer adverse drug reaction reporting add to existing health professional-based systems? Focus on the developing world.

Authors:  Rohini B M Fernandopulle; Krisantha Weerasuriya
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Do pharmacists' reports of adverse drug reactions reflect patients' concerns?

Authors:  Kees van Grootheest; Eugène P van Puijenbroek; Lolkje T W de Jong-van den Berg
Journal:  Pharm World Sci       Date:  2004-06

4.  Signal detection: historical background.

Authors:  Toine C G Egberts
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.

Authors:  Lise Aagaard; Lars Hougaard Nielsen; Ebba Holme Hansen
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

6.  Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications.

Authors:  Stefan Stefanovic; Markus Wallwiener; Uros Karic; Christoph Domschke; Luka Katic; Florin-Andrei Taran; Aleksandra Pesic; Andreas Hartkopf; Peyman Hadji; Martin Teufel; Florian Schuetz; Christof Sohn; Peter Fasching; Andreas Schneeweiss; Sara Brucker
Journal:  Support Care Cancer       Date:  2016-10-17       Impact factor: 3.603

7.  Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance.

Authors:  L Aagaard; C E Hallgreen; E H Hansen
Journal:  Int J Obes (Lond)       Date:  2016-08-01       Impact factor: 5.095

8.  How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme.

Authors:  Lorna Hazell; Victoria Cornelius; Philip Hannaford; Saad Shakir; Anthony J Avery
Journal:  Drug Saf       Date:  2013-03       Impact factor: 5.606

9.  First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.

Authors:  Geneviève Durrieu; Aurore Palmaro; Laure Pourcel; Céline Caillet; Angeline Faucher; Alexis Jacquet; Shéhérazade Ouaret; Marie Christine Perault-Pochat; Carmen Kreft-Jais; Anne Castot; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Drug Saf       Date:  2012-10-01       Impact factor: 5.606

10.  Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand.

Authors:  Narumol Jarernsiripornkul; Sudarat Chaisrisawadsuk; Aporanee Chaiyakum; Janet Krska
Journal:  Pharm World Sci       Date:  2009-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.